ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 137679 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 137679; 2) Community: the network communities that were significantly associated with the response to NSC 137679; 3) Molecule: the relationships between components within communities and NSC 137679; 4) MDR: the compounds that were significantly associated with the NSC 137679.

NSC Compound Enrichment Correlation
NSC 627759 2'-Phenyl-17a-aza-D-homo-5-androsteno[17,16-c]pyrazol-3.beta.-yl acetate 0.0422011701988039 0.049631312
NSC 629910 Null 0.0422011701988039 0.43905623
NSC 639365 1-(3-Diethylamino-2-hydroxypropylamine)-4-(3-chloro-2- hydroxypropylamine)anthraquinone 0.0422011701988039 0.43945433
NSC 643001 3'O-phosphono-(Z)-combretastatin A-4, ammonium salt, hydrate [10:15:4] 0.0422011701988039 0.10824096
NSC 646127 6H-Pyrido[4,3-b]carbazole, 1,2-dihydro-2,5,9,11-tetra- methyl- 0.0422011701988039 -0.24403418
NSC 646847 Bengamide G 0.0422011701988039 0.26970012
NSC 647117 Null 0.0422011701988039 0.14579535
NSC 659949 14-Bromo-7-O-(2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexo- pyranosyl)-4-demethoxydaunomycinone 0.0422011701988039 0.25656478
NSC 667875 Null 0.0422011701988039 0.25068325
NSC 678925 1-Phenazinecarboxamide, N-[2-(dimethylamino)ethyl]- 9-fluoro-, monohydrochloride 0.0422011701988039 0.32170248
Total:75  Current:56    [First] [Prev] [Next] [Last]